News & Updates

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
21 Nov 2022 byStephen Padilla

In patients with solitary metastatic recurrences of prostate cancer, metastasis-directed therapy (MDT without androgen deprivation therapy (ADT) can lead to delayed initiation of systemic therapy, according to a study.

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
21 Nov 2022
Some patient needs not addressed in diabetes care
Some patient needs not addressed in diabetes care
21 Nov 2022
COVID-19 may trigger hair, nail disorders
COVID-19 may trigger hair, nail disorders
21 Nov 2022

Hair and nail disorders may occur following contraction of COVID-19 infection, with the development of the dermatological conditions related to a history of severe infection, a study has found.

COVID-19 may trigger hair, nail disorders
21 Nov 2022